Cargando…

Clinical Efficacy in the Treatment of Overactive Bladder Refractory to Anticholinergics by Posterior Tibial Nerve Stimulation

PURPOSE: Overactive bladder (OAB) is a clinical syndrome that is currently treated initially with anticholinergics, although some other therapeutic alternatives exist, such as neuromodulation, botulinum toxin, and posterior tibial nerve stimulation (PTNS). The purpose of this study was to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arrabal-Polo, Miguel Angel, Palao-Yago, Francisco, Campon-Pacheco, Iluminada, Martinez-Sanchez, Maribel, Zuluaga-Gomez, Armando, Arrabal-Martin, Miguel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406195/ https://www.ncbi.nlm.nih.gov/pubmed/22866220 http://dx.doi.org/10.4111/kju.2012.53.7.483

Ejemplares similares

Refractory overactive bladder: Beyond oral anticholinergic therapy
por: Glinski, Ronald W., et al.
Publicado: (2007)

Posterior tibial nerve stimulation as treatment for the overactive bladder
por: Sherif, Hammouda, et al.
Publicado: (2013)

Posterior tibial nerve stimulation for overactive bladder—techniques and efficacy
por: Bhide, Alka A., et al.
Publicado: (2019)

Electrostimulation of the posterior tibial nerve in individuals with overactive bladder: a literature review
por: Garcia, Marilia Barbosa Santos, et al.
Publicado: (2018)

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines
por: Al-Danakh, Abdullah, et al.
Publicado: (2022)

Solifenacin versus posterior tibial nerve stimulation for overactive bladder in patients with multiple sclerosis
por: Majdinasab, Nastaran, et al.
Publicado: (2023)

Effect of Desmopressin with Anticholinergics in Female Patients with Overactive Bladder
por: Han, Young Kook, et al.
Publicado: (2011)

Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder
por: Araklitis, George, et al.
Publicado: (2020)

Do Failure of Posterior Tibial Nerve Stimulation Precludes to Use Sacral Neuromodulation in Patient With Overactive Bladder?
por: Berthelot, Louis-Paul, et al.
Publicado: (2019)

The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder
por: Gurocak, Serhat, et al.
Publicado: (2015)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
por: Sartori, Luisa Gracio Ferreira, et al.
Publicado: (2023)

Metabolic Syndrome, Hormone Levels, and Inflammation in Patients with Erectile Dysfunction
por: Arrabal-Polo, Miguel Ángel, et al.
Publicado: (2012)

Percutaneous Tibial Nerve Stimulation in the Treatment of Refractory Idiopathic Overactive Bladder Syndrome: A Retrospective Cohort Study
por: Frey, Janine Nicole, et al.
Publicado: (2023)

Meta-Analysis of Studies Analyzing the Role of Human Papillomavirus in the Development of Bladder Carcinoma
por: Jimenez-Pacheco, Antonio, et al.
Publicado: (2012)

Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome
por: de Wall, Liesbeth L, et al.
Publicado: (2017)

Bone and Metabolic Markers in Women With Recurrent Calcium Stones
por: Arrabal-Polo, Miguel Angel, et al.
Publicado: (2013)

Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder
por: Jaggi, Ashley, et al.
Publicado: (2021)

Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics
por: Yehoshua, Alon, et al.
Publicado: (2016)

Treatment for overactive bladder: A meta-analysis of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation
por: Yang, Ding-Yuan, et al.
Publicado: (2021)

Efficacy of Transcutaneous Tibial Nerve Stimulation With Silver Spike Point® Electrodes for Refractory Overactive Bladder: A Single-Arm Study
por: Kaga, Kanya, et al.
Publicado: (2023)

Adjuvant intravesical treatment in patients with intermediate and high-risk non-muscle-invasive bladder cancer with BCG versus MMC applied with COMBAT or EMDA. Results of a prospective study
por: Arrabal Polo, Miguel Ángel, et al.
Publicado: (2023)

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2014)

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
por: Elbaset, M.A., et al.
Publicado: (2019)

Patient‐tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms
por: te Dorsthorst, Manon, et al.
Publicado: (2022)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2015)

Fall/Fracture-Related Healthcare Costs and Their Association with Cumulative Anticholinergic Burden in People with Overactive Bladder
por: Lozano-Ortega, Greta, et al.
Publicado: (2020)

Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review
por: Dmochowski, Roger R., et al.
Publicado: (2023)

Foreskin trapped by zipper: a case report
por: Arrabal-Polo, Miguel Angel, et al.
Publicado: (2009)

Percutaneous versus Transcutaneous Electrical Stimulation of the Posterior Tibial Nerve in Idiopathic Overactive Bladder Syndrome with Urinary Incontinence in Adults: A Systematic Review
por: Agost-González, Aida, et al.
Publicado: (2021)

Hiperparatiroidismo en pacientes con litiasis. Influencia del déficit de 25-OH vitamina D
por: Arrabal-Polo, Miguel Ángel, et al.
Publicado: (2016)

Refractory overactive bladder: a common problem?
por: Schwantes, Ulrich, et al.
Publicado: (2015)

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care
por: Staskin, David R., et al.
Publicado: (2012)

Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study
por: Cava, Robert, et al.
Publicado: (2022)

The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
por: Masumori, Naoya, et al.
Publicado: (2011)

Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports
por: Shiota, Takako, et al.
Publicado: (2014)

Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects
por: Çetinel, Bülent, et al.
Publicado: (2013)

Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real‐world claims data analysis
por: Sussman, D., et al.
Publicado: (2017)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder
por: Sievert, K-D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o7dktmqpksdqomh8l15sr2lm0i